U
Khiron Life Sciences Corp.
KHRNH.V
TSX
E
Sell
3/14/2023Downgrade
Khiron Life Sciences Corp. (KHRN.V) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
Khiron Life Sciences Corp. (KHRN.V) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
D
Sell
2/9/2023Upgraded
Khiron Life Sciences Corp. (KHRN.V) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
Khiron Life Sciences Corp. (KHRN.V) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
E
Sell
2/8/2023Downgrade
Khiron Life Sciences Corp. (KHRN.V) was downgraded to E+ from D on 2/8/2023 due to a decline in the volatility index.
Khiron Life Sciences Corp. (KHRN.V) was downgraded to E+ from D on 2/8/2023 due to a decline in the volatility index.
D
Sell
1/31/2023Upgraded
Khiron Life Sciences Corp. (KHRN.V) was upgraded to D from D- on 1/31/2023 due to an increase in the volatility index and total return index.
Khiron Life Sciences Corp. (KHRN.V) was upgraded to D from D- on 1/31/2023 due to an increase in the volatility index and total return index.
D
Sell
12/1/2022Downgrade
Khiron Life Sciences Corp. (KHRN.V) was downgraded to D- from D on 12/1/2022 due to a major decline in the growth index, solvency index and total return index. Operating cash flow declined 146.47% from -$1.57M to -$3.86M, earnings per share declined from -$0.0091 to -$0.0153, and debt to equity increased from 0.04 to 0.06.
Khiron Life Sciences Corp. (KHRN.V) was downgraded to D- from D on 12/1/2022 due to a major decline in the growth index, solvency index and total return index. Operating cash flow declined 146.47% from -$1.57M to -$3.86M, earnings per share declined from -$0.0091 to -$0.0153, and debt to equity increased from 0.04 to 0.06.
D
Sell
6/1/2022Upgraded
Khiron Life Sciences Corp. (KHRN.V) was upgraded to D from D- on 6/1/2022 due to a major increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.0865 to -$0.0238, operating cash flow increased 46.02% from -$4.1M to -$2.21M, and total revenue increased 27.02% from $2.89M to $3.67M.
Khiron Life Sciences Corp. (KHRN.V) was upgraded to D from D- on 6/1/2022 due to a major increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.0865 to -$0.0238, operating cash flow increased 46.02% from -$4.1M to -$2.21M, and total revenue increased 27.02% from $2.89M to $3.67M.
D
Sell
5/16/2022Upgraded
Khiron Life Sciences Corp. (KHRN.V) was upgraded to D- from E+ on 5/16/2022 due to an increase in the valuation index.
Khiron Life Sciences Corp. (KHRN.V) was upgraded to D- from E+ on 5/16/2022 due to an increase in the valuation index.
E
Sell
5/1/2022Downgrade
Khiron Life Sciences Corp. (KHRN.V) was downgraded to E+ from D on 5/1/2022 due to a substantial decline in the growth index, valuation index and solvency index. Debt to equity increased from 0.01 to 0.07, the quick ratio declined from 2.99 to 1.53, and EBIT declined 14.3% from -$3.65M to -$4.18M.
Khiron Life Sciences Corp. (KHRN.V) was downgraded to E+ from D on 5/1/2022 due to a substantial decline in the growth index, valuation index and solvency index. Debt to equity increased from 0.01 to 0.07, the quick ratio declined from 2.99 to 1.53, and EBIT declined 14.3% from -$3.65M to -$4.18M.
D
Sell
4/21/2022Upgraded
Khiron Life Sciences Corp. (KHRNH.V) was upgraded to D from E+ on 04/21/2022.
Khiron Life Sciences Corp. (KHRNH.V) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
Khiron Life Sciences Corp. (KHRN.V) was downgraded to E+ from D on 4/20/2022 due to a decline in the solvency index, volatility index and total return index.
Khiron Life Sciences Corp. (KHRN.V) was downgraded to E+ from D on 4/20/2022 due to a decline in the solvency index, volatility index and total return index.
D
Sell
11/9/2021Upgraded
Khiron Life Sciences Corp. (KHRNH.V) was upgraded to D from E+ on 11/09/2021.
Khiron Life Sciences Corp. (KHRNH.V) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
Khiron Life Sciences Corp. (KHRN.V) was downgraded to E+ from D on 11/8/2021 due to a decline in the solvency index, total return index and volatility index.
Khiron Life Sciences Corp. (KHRN.V) was downgraded to E+ from D on 11/8/2021 due to a decline in the solvency index, total return index and volatility index.
D
Sell
8/24/2021Upgraded
Khiron Life Sciences Corp. (KHRN.V) was upgraded to D from D- on 8/24/2021 due to a significant increase in the growth index. Operating cash flow increased 72.5% from -$6.47M to -$1.78M, earnings per share increased from -$0.0316 to -$0.0244, and EBIT increased 12.59% from -$4.34M to -$3.8M.
Khiron Life Sciences Corp. (KHRN.V) was upgraded to D from D- on 8/24/2021 due to a significant increase in the growth index. Operating cash flow increased 72.5% from -$6.47M to -$1.78M, earnings per share increased from -$0.0316 to -$0.0244, and EBIT increased 12.59% from -$4.34M to -$3.8M.
D
Sell
7/29/2021Downgrade
Khiron Life Sciences Corp. (KHRN.V) was downgraded to D- from D on 7/29/2021 due to a major decline in the growth index, volatility index and solvency index. EBIT declined 166.71% from -$1.63M to -$4.34M, earnings per share declined from -$0.014 to -$0.0316, and operating cash flow declined 46.83% from -$4.41M to -$6.47M.
Khiron Life Sciences Corp. (KHRN.V) was downgraded to D- from D on 7/29/2021 due to a major decline in the growth index, volatility index and solvency index. EBIT declined 166.71% from -$1.63M to -$4.34M, earnings per share declined from -$0.014 to -$0.0316, and operating cash flow declined 46.83% from -$4.41M to -$6.47M.
D
Sell
5/1/2020Upgraded
Khiron Life Sciences Corp. (KHRN.V) was upgraded to D from D- on 5/1/2020 due to a major increase in the growth index and valuation index. Earnings per share increased from -$0.0706 to -$0.049, and EBIT increased 20.48% from -$8.24M to -$6.56M.
Khiron Life Sciences Corp. (KHRN.V) was upgraded to D from D- on 5/1/2020 due to a major increase in the growth index and valuation index. Earnings per share increased from -$0.0706 to -$0.049, and EBIT increased 20.48% from -$8.24M to -$6.56M.
D
Sell
9/30/2019Downgrade
Khiron Life Sciences Corp. (KHRN.V) was downgraded to D- from D on 9/30/2019 due to a decline in the total return index and volatility index.
Khiron Life Sciences Corp. (KHRN.V) was downgraded to D- from D on 9/30/2019 due to a decline in the total return index and volatility index.
D
Sell
8/27/2019Upgraded
Khiron Life Sciences Corp. (KHRN.V) was upgraded to D from D- on 8/27/2019 due to a major increase in the solvency index, total return index and valuation index. The quick ratio increased from 4.62 to 7.62, and debt to equity declined from 0.05 to 0.04.
Khiron Life Sciences Corp. (KHRN.V) was upgraded to D from D- on 8/27/2019 due to a major increase in the solvency index, total return index and valuation index. The quick ratio increased from 4.62 to 7.62, and debt to equity declined from 0.05 to 0.04.
D
Sell
2/1/2019Upgraded
Khiron Life Sciences Corp. (KHRN.V) was upgraded to D- from E+ on 2/1/2019 due to a large increase in the growth index, solvency index and total return index. The quick ratio increased from 3.68 to 8.48, earnings per share increased from -$0.1186 to -$0.081, and EBIT increased 21.52% from -$5.14M to -$4.03M.
Khiron Life Sciences Corp. (KHRN.V) was upgraded to D- from E+ on 2/1/2019 due to a large increase in the growth index, solvency index and total return index. The quick ratio increased from 3.68 to 8.48, earnings per share increased from -$0.1186 to -$0.081, and EBIT increased 21.52% from -$5.14M to -$4.03M.
E
Sell
11/1/2018Upgraded
Khiron Life Sciences Corp. (KHRN.V) was upgraded to E+ from E on 11/1/2018 due to a noticeable increase in the total return index and volatility index.
Khiron Life Sciences Corp. (KHRN.V) was upgraded to E+ from E on 11/1/2018 due to a noticeable increase in the total return index and volatility index.
E
Sell
9/4/2018Upgraded
Khiron Life Sciences Corp. (KHRN.V) was upgraded to E from E- on 9/4/2018 due to a noticeable increase in the volatility index and total return index.
Khiron Life Sciences Corp. (KHRN.V) was upgraded to E from E- on 9/4/2018 due to a noticeable increase in the volatility index and total return index.
E
Sell
8/31/2018None
Khiron Life Sciences Corp. (KHRNH.V) was downgraded to E- from U on 08/31/2018.
Khiron Life Sciences Corp. (KHRNH.V) was downgraded to E- from U on 08/31/2018.
